105 related articles for article (PubMed ID: 15617169)
1. [Risk factors of early drop-out during induction of high-dose buprenorphine substitution therapy. A study of 1085 opiate addicts].
Batel P; Reynaud-Maurupt C; Lavignasse P; Constant MV; Kopp P; Jourdain JJ; Videau B; Mucchielli A; Riff B; Lowenstein W
Presse Med; 2004 Oct; 33(18 Suppl):5-9. PubMed ID: 15617169
[TBL] [Abstract][Full Text] [Related]
2. Economic and social effects of high-dose buprenorphine substitution therapy. Six-month results.
Lavignasse P; Lowenstein W; Batel P; Constant MV; Jourdain JJ; Kopp P; Reynaud-Maurupt C; Riff B; Videau B; Mucchielli A
Ann Med Interne (Paris); 2002 May; 153(3 Suppl):1S20-6. PubMed ID: 12218879
[TBL] [Abstract][Full Text] [Related]
3. [Buprenorphine abuse: high dose intravenous administration of buprenorphine].
Varescon I; Vidal-Trécan G; Nabet N; Boissonnas A
Encephale; 2002; 28(5 Pt 1):397-402. PubMed ID: 12386540
[TBL] [Abstract][Full Text] [Related]
4. Examining the influence of drop-outs in a follow-up of maintained opiate users.
Encrenaz G; Rondeau V; Messiah A; Auriacombe M
Drug Alcohol Depend; 2005 Sep; 79(3):303-10. PubMed ID: 16102374
[TBL] [Abstract][Full Text] [Related]
5. [Absence of correlation between mental disorders and high-dose buprenorphine. A case-control study].
Phan O; Sanchez M; Bouthillon-Heitzmann P
Presse Med; 2005 Jun; 34(10):711-8. PubMed ID: 16026124
[TBL] [Abstract][Full Text] [Related]
6. [High-dose buprenorphine substitution during incarceration. Management of opiate addicts].
Revnaud-Maurupt C; Caer Y; Escaffre N; Gagneau M; Galinier A; Marzo JN; Meroueh F
Presse Med; 2005 Apr; 34(7):487-90. PubMed ID: 15902999
[TBL] [Abstract][Full Text] [Related]
7. HIV treatment access and scale-up for delivery of opiate substitution therapy with buprenorphine for IDUs in Ukraine--programme description and policy implications.
Bruce RD; Dvoryak S; Sylla L; Altice FL
Int J Drug Policy; 2007 Aug; 18(4):326-8. PubMed ID: 17689382
[TBL] [Abstract][Full Text] [Related]
8. [Two-year follow-up of an opioid-user cohort treated with high-dose buprenorphine (Subutex)].
Fhima A; Henrion R; Lowenstein W; Charpak Y
Ann Med Interne (Paris); 2001 Apr; 152 Suppl 3():IS26-36. PubMed ID: 11435992
[TBL] [Abstract][Full Text] [Related]
9. [Characteristics of subjects under opiate maintenance treatment in primary care using the OPEMA data 2013].
Gentile G; Frauger E; Giocanti A; Pauly V; Orleans V; Amaslidou D; Thirion X; Micallef J;
Therapie; 2016 Jun; 71(3):307-13. PubMed ID: 27235654
[TBL] [Abstract][Full Text] [Related]
10. Early Discontinuation of Buprenorphine Therapy for Opioid Use Disorder Among Privately Insured Adults.
Agbese E; Leslie DL; Manhapra A; Rosenheck R
Psychiatr Serv; 2020 Aug; 71(8):779-788. PubMed ID: 32264801
[TBL] [Abstract][Full Text] [Related]
11. Balancing access and safety in prescribing opioid agonist therapy to prevent HIV transmission.
Bachireddy C; Weisberg DF; Altice FL
Addiction; 2015 Dec; 110(12):1869-71. PubMed ID: 26464200
[No Abstract] [Full Text] [Related]
12. [The profile of drug addicts attending the Sainte Marguerite University Hospital in Marseille analysis of the active file from 1996 to 2001].
Lançon C; Jaquet I; Labrune N; Bartolo K; De Stopeleire C; Auquier P
Presse Med; 2004 Oct; 33(18 Suppl):11-7. PubMed ID: 15617170
[TBL] [Abstract][Full Text] [Related]
13. [Therapeutic strategies for opioid addiction: the role of substitution therapy].
; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ; ;
Presse Med; 2004 Oct; 33(18 Suppl):41-7. PubMed ID: 15617175
[No Abstract] [Full Text] [Related]
14. Prospective multicenter observational study of 260 infants born to 259 opiate-dependent mothers on methadone or high-dose buprenophine substitution.
Lejeune C; Simmat-Durand L; Gourarier L; Aubisson S;
Drug Alcohol Depend; 2006 May; 82(3):250-7. PubMed ID: 16257138
[TBL] [Abstract][Full Text] [Related]
15. Psychiatric Comorbidity and Substance Use Outcomes in an Office-Based Buprenorphine Program Six Months Following Hurricane Sandy.
Tofighi B; Grossman E; Goldfeld KS; Williams AR; Rotrosen J; Lee JD
Subst Use Misuse; 2015; 50(12):1571-8. PubMed ID: 26623697
[TBL] [Abstract][Full Text] [Related]
16. Optimising the benefits of unobserved dose administration for stable opioid maintenance patients: follow-up of a randomised trial.
Bell JR; Ryan A; Mutch C; Batey R; Rea F
Drug Alcohol Depend; 2008 Jul; 96(1-2):183-6. PubMed ID: 18423901
[TBL] [Abstract][Full Text] [Related]
17. Linking patients with buprenorphine treatment in primary care: Predictors of engagement.
Simon CB; Tsui JI; Merrill JO; Adwell A; Tamru E; Klein JW
Drug Alcohol Depend; 2017 Dec; 181():58-62. PubMed ID: 29035705
[TBL] [Abstract][Full Text] [Related]
18. Ultra-rapid opiate detoxification using deep sedation and prior oral buprenorphine preparation: long-term results.
Bochud Tornay C; Favrat B; Monnat M; Daeppen JB; Schnyder C; Bertschy G; Besson J
Drug Alcohol Depend; 2003 Apr; 69(3):283-8. PubMed ID: 12633914
[TBL] [Abstract][Full Text] [Related]
19. [Two years follow-up of a heroin users cohort treated with high dosage buprenorphine. Results of the SPESUB study (pharmacoepidemiologic follow-up of general practice Subutex)].
Duburcq A; Charpak Y; Blin P; Madec L
Rev Epidemiol Sante Publique; 2000 Aug; 48(4):363-73. PubMed ID: 11011303
[TBL] [Abstract][Full Text] [Related]
20. Clinical profile of responders to buprenorphine as a substitution treatment in heroin addicts: results of a multicenter study of 73 patients.
Poirier MF; Laqueille X; Jalfre V; Willard D; Bourdel MC; Fermanian J; Olié JP
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):267-72. PubMed ID: 14751421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
